Chelation therapy is gaining worldwide acceptance and is becoming a standard medical treatment in many countries although still suppressed and opposed by those who have little interest in the advancing beyond the established and profitable approaches to circulatory disorders. Increasing number of physicians and scientists are coming to the conclusion that chelation therapy has tremendous potential in the treatment of atherosclerosis and many other disorders.
In North America, in the year 1997 there were 800,000 people who underwent the therapy, and 880,000 people in 1998 reported. Since the year 2000 onwards there have been more than one million people who underwent this treatment yearly. There are many quarters who claimed that chelation therapy has no study. It is somewhat true when they refer to double blind control study. However there were enough evidence to support the effectiveness of the therapy.